Skip to main content
. 2023 Jul 12;4(8):469–477. doi: 10.1016/j.hroo.2023.07.003

Table 2.

Distribution of single-lead rhythm assessment results in patients with diagnosed AF in the intervention arm at the first visit with completed rhythm assessment and according to the most abnormal result

Possible AF Unclassified Normal No analysis
First visit with rhythm assessment
 All 636 (31.5) 348 (17.2) 884 (43.7) 154 (7.6)
 Age (y)
 65–74 201 (26.6) 104 (13.8) 410 (54.3) 40 (5.3)
 75–84 305 (35.2) 158 (18.2) 305 (40.1) 56 (6.5)
 ≥85 130 (32.5) 86 (21.5) 126 (31.5) 58 (14.5)
 OAC at baseline
 No 126 (19.2) 106 (16.1) 381 (58.0) 44 (6.7)
 Yes 510 (37.4) 242 (17.7) 503 (36.8) 110 (8.1)
 Previous stroke
 No 496 (31.3) 273 (17.2) 704 (44.4) 114 (7.2)
 Yes 140 (32.2) 75 (17.2) 180 (41.4) 40 (9.2)
 CHA2DS2-VASc score
 Low risk 10 (21.7) 5 (10.9) 29 (63.0) 2 (4.3)
 Moderate risk 190 (28.7) 91 (13.7) 350 (52.8) 32 (4.8)
 High risk 436 (33.2) 252 (19.2) 505 (38.5) 120 (9.1)
 Transient AF in setting of secondary precipitant
 No (n = 719) 201 (28.0) 124 (17.2) 340 (47.3) 54 (7.5)
 Yes (n = 107) 7 (6.5) 18 (16.8) 79 (73.8) 3 (2.8)
Most “Abnormal” rhythm assessment
 All 811 (40.1) 382 (18.9) 737 (36.4) 92 (4.5)
 Age (y)
 65–74 256 (33.9) 119 (15.8) 358 (47.4) 22 (2.9)
 75–84 373 (43.0) 174 (20.1) 288 (33.2) 32 (3.7)
 ≥85 182 (45.5) 89 (22.3) 91 (22.8) 38 (9.5)
 OAC at baseline
 No 166 (25.3) 143 (21.8) 319 (48.6) 29 (4.4)
 Yes 645 (47.3) 239 (17.5) 418 (30.6) 63 (4.6)
 Previous stroke
 No 619 (39.0) 298 (18.8) 597 (37.6) 73 (4.6)
 Yes 192 (44.1) 84 (19.3) 140 (32.2) 19 (4.4)
 CHA2DS2-VASc score
 Low risk 13 (28.3) 4 (8.7) 28 (60.9) 1 (2.2)
 Moderate risk 222 (33.5) 110 (16.6) 309 (46.6) 22 (3.3)
 High risk 576 (43.9) 268 (20.4) 400 (30.5) 69 (5.3)
 Transient AF in setting of secondary precipitant
 No (n = 719) 255 (35.5) 136 (18.9) 292 (40.6) 36 (5.0)
 Yes (n = 107) 13 (12.1) 28 (26.2) 64 (59.8) 2 (1.9)

Values are given as n (%).

AF = atrial fibrillation; OAC = oral anticoagulation.

Low risk: 1 (men), 2 (women); Moderate risk: 2–3 (men), 3–4 (women); High risk: 4+ (men), 5+ (women).

As determined by chart review among a subset of the sample (n = 826).